PPT-Abuse Deterrent Opioids: The Promise and the perils

Bob Twillman PhD FAPM Executive Director American Academy of Pain Management Two Major Public Health Problems Prescription opioid abuse 125 million nonmedical users per year 70120 billion cost per year. Bob Twillman, Ph.D., FAPM. Executive . Director. American . Academy of Pain Management. Two Major Public Health Problems. Prescription . opioid abuse. :. 12.5 million non-medical users per year. $70-120 billion cost per year. Bob Sammons, M.D., Ph.D.. Mesa Behavioral Medicine Clinic. TMS Solutions. Conflict of interest. None.      Dr. Sammons received a bachelors and master’s degree from Auburn University, a PhD in clinical psychology from the University of North Carolina at Greensboro, and a medical degree from the University of North Carolina at Chapel Hill.  He did a residency in psychiatry at the University of Virginia as well as a forensic fellowship.  While serving in the United States Air Force as a squad commander and captain, he was selected as one of 5 psychologist to establish the opiate treatment phase of the drug treatment program for the Department of Air Force in 1972.  For this he receive the  Meritorious Service Medal.  He has practiced adult psychiatry in Grand Junction for 28 years.  He is 1 of 2 physicians in town that have received specialist training and a special DEA number that allows him to prescribe Suboxone treatment for opiate dependency.. Wayne Winegarden, Ph.D.. Sr. Fellow, Business & Economics, Pacific Research Institute. Contributing Editor, EconoSTATS a project of George Mason University. Partner, Capitol Economic Advisors. Presentation CWAG Annual Conference. Prescription opioid abuse and the resurgence of heroin. Opioid Crisis Summit Meeting. October 17, . 2017. Dr. Theodore J. Cicero, PhD. Washington University in St. Louis,. Department of Psychiatry. Email: . a Law enforcement. perspective. Charlie Cichon. Executive Director. The National Association of Drug Diversion Investigators (NADDI). The National Association of Drug Diversion Investigators, or NADDI, is a non-profit membership organization that works to develop and implement solutions to the problem of prescription drug diversion. . FDA’s Role and . Emerging Challenges. Jeanne Ireland. Principal, Ireland Strategies, LLC. 2015 CWAG Annual Meeting. The Opioid Epidemic. Some progress being made, but devastating effects of epidemic continue. Joshua P. Cohen, PhD. Massachusetts State House. February 5, 2018. 20% of non-cancer pain patients are prescribed an . opioid. , compared to <5% in other industrialized nations. U.S. has 4% of the world’s population, yet 30% of global . Bureau of Health Care Safety and Quality. Department of Public Health. July 14, 2016. Review of June 2. nd. meeting. Non-Opioid Pain Management List. . Draft Formulary Guidance. Next Steps. Slide . Bureau of Health Care Safety and Quality. Department of Public Health. December 15, 2016. Draft Formulary (105 CMR 720). Schedule. Amendments. Comments. Guidance. Interchangeable Abuse Deterrent Drug Products Evaluation. a Law enforcement. perspective. Charlie Cichon. Executive Director. The National Association of Drug Diversion Investigators (NADDI). The National Association of Drug Diversion Investigators, or NADDI, is a non-profit membership organization that works to develop and implement solutions to the problem of prescription drug diversion. . Effectiveness and Value. Presentation to the Massachusetts Drug Formulary Commission. February 5, 2018. Presentation Agenda. Introduction to ICER. Comparative clinical effectiveness of abuse-deterrent formulations of opioids (ADFs). Psycho-Education for Patients and Family Members. 12-. 1. The Importance of Total Abstinence. Abstinence from all substances that affect the brain—even alcohol—greatly increases the chances of a successful recovery.. In Better than Human?, noted bioethicist Allen Buchanan grapples with the ethical dilemmas of the medical revolution now upon us. Biomedical enhancements, he writes, can make us smarter, have better memories, be stronger, quicker, have more stamina, live much longer, be more resistant to disease and to the frailties of aging, and enjoy richer emotional lives. They can even improve our character, or at least strengthen our powers of self-control. In spite of the benefits that biomedical enhancements may bring, many people instinctively reject them. Some worry that we will lose something important-our appreciation for what we have or what makes human beings distinctively valuable. To think clearly about enhancement, Buchanan argues, we have to acknowledge that nature is a mixed bag and that our species has many design flaws. We should be open to the possibility of becoming better than human, while never underestimating the risk that our attempts to improve may backfire. It’s no secret that this world we live in can be pretty stressful sometimes. If you find yourself feeling out-of-sorts, pick up a book.According to a recent study, reading can significantly reduce stress levels. In as little as six minutes, you can reduce your stress levels by 68%.